Further studies on ethenyl and ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of a subnanomolar Src kinase inhibitor
- 15 March 2005
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (6), 1743-1747
- https://doi.org/10.1016/j.bmcl.2005.01.004
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A renaissance for SRCNature Reviews Cancer, 2004
- 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as Dual Inhibitors of Src and Abl KinasesJournal of Medicinal Chemistry, 2004
- Investigation of the effect of varying the 4-anilino and 7-alkoxy groups of 3-quinolinecarbonitriles on the inhibition of Src kinase activityBioorganic & Medicinal Chemistry Letters, 2003
- Targeting Protein Kinases for Bone Disease: Discovery and Development of Src InhibitorsCurrent Pharmaceutical Design, 2002
- Inhibition of Src kinase activity by 4-anilino-7-thienyl-3-quinolinecarbonitrilesBioorganic & Medicinal Chemistry Letters, 2002
- Role of Src in Signal Transduction PathwaysBiochemical Society Transactions, 2002
- Optimization of 4-Phenylamino-3-quinolinecarbonitriles as Potent Inhibitors of Src Kinase ActivityJournal of Medicinal Chemistry, 2001
- Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitrilesJournal of Medicinal Chemistry, 2001
- Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?Trends in Pharmacological Sciences, 2000
- Inhibitors of Src tyrosine kinase: the preparation and structure–activity relationship of 4-anilino-3-cyanoquinolines and 4-anilinoquinazolinesBioorganic & Medicinal Chemistry Letters, 2000